Mounjaro (tirzepatide) is one of the most effective licensed weight management medications available in the UK. Like all medicines, it can cause side effects — particularly in the early weeks of treatment. Understanding what to expect, and knowing how to respond, can make a significant difference to your experience on the medication.

This guide covers every common and clinically significant side effect associated with tirzepatide, drawing on the Summary of Product Characteristics (SmPC), NICE guidance, and published SURMOUNT trial data. It also provides clear, evidence-informed management strategies for each.

Why Do Side Effects Occur with Mounjaro?

Tirzepatide activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This dual mechanism is what drives its superior efficacy — but the same pathways also explain most of its gastrointestinal side effects.

GLP-1 receptors are found throughout the gut. Stimulating them slows gastric emptying (the rate at which food moves from the stomach to the small intestine) and alters gastrointestinal motility. This is beneficial for appetite control and blood glucose regulation but can cause nausea, vomiting, diarrhoea, and constipation — particularly when the dose is increased.

The dose-escalation schedule built into tirzepatide prescribing (starting at 2.5mg and increasing every four weeks) is specifically designed to reduce side effect burden by allowing the body to adapt gradually.

Complete Side Effect Profile: Frequency and Management

Frequency categories are taken from the EU Summary of Product Characteristics for tirzepatide. 'Very common' means affecting more than 1 in 10 patients; 'common' means affecting 1–10 in 100 patients.

Managing the Most Common Side Effects in Detail

Nausea

Nausea is the most frequently reported side effect and the most common reason patients consider discontinuing treatment. It is usually most pronounced in the first 1–2 weeks of each new dose level and typically improves significantly over time.

Evidence-based management strategies:

•       Eat bland, lower-fat foods such as plain rice, toast, boiled chicken, or crackers

•       Avoid fatty, fried, or highly seasoned meals

•       Eat smaller portions more frequently, rather than three large meals

•       Do not lie down for at least 30 minutes after eating

•       Stay well hydrated throughout the day — sip fluids rather than gulping

•       Ginger (in tea, biscuit, or supplement form) has modest clinical evidence for nausea relief

•       If nausea is severe, contact your prescriber — they may recommend a slower dose escalation schedule

Diarrhoea and Constipation

Both loose stools and constipation can occur, sometimes alternating. This reflects the impact of tirzepatide on gut motility.

For diarrhoea:

•       Maintain good fluid intake to prevent dehydration — oral rehydration sachets (ORS) are available over the counter

•       Avoid high-fibre, spicy, or greasy foods temporarily

•       If diarrhoea is frequent or watery, consult your prescriber

For constipation:

•       Gradually increase dietary fibre — fruits, vegetables, whole grains

•       Aim for at least 1.5–2 litres of fluid daily

•       Light physical activity (walking) helps stimulate bowel motility

•       A pharmacist can recommend a suitable osmotic laxative if dietary measures are insufficient

Fatigue

Some patients experience mild fatigue, particularly in the early weeks of treatment or following dose increases. This may relate to reduced caloric intake, changes in blood glucose regulation, or adjustment to the medication.

•       Ensure you are eating regular meals and meeting your protein targets (approximately 1.2–1.6g per kg of body weight per day is often recommended during weight loss — verify with your dietitian)

•       Adequate sleep and rest is important, especially during active weight loss

•       If fatigue is persistent or severe, speak to your prescriber to rule out other causes

Hair Loss (Telogen Effluvium)

Hair loss during Mounjaro treatment is common and causes understandable anxiety. However, it is important to understand that this is almost always a consequence of rapid weight loss rather than a direct pharmacological effect of tirzepatide.

Telogen effluvium is a temporary condition in which the hair growth cycle is disrupted by physical stress (including significant caloric restriction). Hair shedding typically occurs approximately 3–6 months after the triggering event and is self-limiting — meaning it resolves on its own in most cases.

•       Ensure adequate protein intake to support hair follicle health

•       Consider a multivitamin with iron, zinc, and biotin — discuss with your pharmacist

•       Avoid aggressive heat styling or tight hairstyles during this period

•       Reassurance: hair density typically recovers once weight loss stabilises

Injection Site Reactions

Redness, itching, bruising, or small lumps at the injection site are common, particularly in the early weeks. These are usually mild and resolve quickly.

•       Rotate injection sites with every dose — abdomen, thigh, and upper arm are all suitable

•       Avoid injecting into the same spot repeatedly, which can cause lipohypertrophy (a buildup of fatty tissue)

•       Allow the pen to reach room temperature before injecting if stored in the fridge

•       Do not rub the injection site after administration

•       Significant swelling, warmth, or pus at the site should be assessed by a clinician

Serious Side Effects: When to Seek Urgent Help

The SURMOUNT clinical trials reported very low rates of serious adverse events. Pancreatitis occurred in fewer than 1% of participants, and severe allergic reactions are rare based on post-marketing surveillance data. You may want to verify the most current pharmacovigilance data from the MHRA or the EU SmPC for tirzepatide.

Dose Escalation and Side Effect Burden

One of the most clinically important aspects of Mounjaro management is that most side effects are closely linked to dose changes. The standard escalation schedule is as follows:

Not all patients require titration to the maximum 15mg dose. Your clinician will determine the appropriate maintenance dose based on your weight loss response and tolerability.

Tips for Tolerating Mounjaro Better

Frequently Asked Questions

How long do Mounjaro side effects last?

Gastrointestinal side effects are typically most intense in the first 1–2 weeks of each new dose level and usually subside substantially within 4–6 weeks. For many patients, side effects are minimal or absent at the maintenance dose.

What should I do if I can't tolerate a dose increase?

Contact your prescriber. It is clinically acceptable to remain on a lower dose for longer, or to return to a previous dose, before attempting escalation again. Do not make this decision independently without medical guidance.

Can I take anti-sickness medication with Mounjaro?

Some anti-emetic medications may be appropriate — but this must be discussed with your prescriber or pharmacist. Do not self-medicate with prescription anti-emetics. Over-the-counter options such as domperidone (available from pharmacies in limited doses) or ginger preparations may be discussed with your pharmacist.

Is it safe to exercise while experiencing side effects?

Gentle activity such as walking is generally safe and can help with digestive symptoms. Avoid intense exercise if you are experiencing vomiting or diarrhoea due to the risk of dehydration. Listen to your body and discuss any concerns with your prescriber.

Should I stop Mounjaro if I experience side effects?

Most side effects are manageable and temporary. Do not stop your medication without consulting your prescriber, as abrupt discontinuation can reverse weight loss progress. Your clinical team can adjust your schedule or dose to improve tolerability.